Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Seoul
Clinical trial register · South Korea

Clinical Trials in Seoul, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3365 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:17 UTC
3365
Studies in scope
all four open statuses
1831
Recruiting now
open to new participants
500
Lead sponsors
across recruiting studies
Top sites
Seoul 30 Daegu 8 Ansan-si 7 Busan 6 Seongnam-si 6
Narrow the registerReset
Recruitment status
Phase
Site location
Seoul30 Daegu8 Ansan-si7 Busan6 Seongnam-si6
All 26 locations
Target enrolment
to

Trials with a site in Seoul

30 of 3365 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Not yet open
Post-marketing Surveillance Study for the Safety of Efluelda Tetra Pre-filled Syringe.
NCT06694025Immunization, Influenza (Healthy Volunteers)
Sanofi
Observational
670
Seoul
2026-10-01
Recruiting
Sanofi
Observational
706
Busan, Daegu, Goyang, Gwangju, Hanam, Iksan, Seongnam, Seoul
2026-07-01
Recruiting
Sanofi
Phase 3
980
Ansan-si, Busan, Daegu, Daejeon, Gwangju, Seoul, Suwon
2025-10-01
Recruiting
Sanofi
Phase 3
124
Suwon, Seoul
2025-09-26
Recruiting
Sanofi
Phase 4
218
Anyang-si, Seoul
2025-09-22
By invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
NCT06859099Polyneuropathy, Inflammatory Demyelinating, Chronic
Sanofi
Phase 3
300
Seoul
2025-04-01
Active, closed
Sanofi
Phase 3
231
Cheonan-Si, Seongnam-si, Incheon, Seoul
2025-02-12
By invitation
Sanofi
Phase 2
900
Seoul
2024-09-30
Active, closed
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
NCT06290128Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic
Sanofi
Phase 3
109
Seoul
2024-07-12
Recruiting
Sanofi
Phase 1
96
Busan, Goyang-si, Seoul
2024-07-08
Active, closed
Sanofi
Phase 3
1,541
Daegu, Gwangju, Ansan-si, Seongnam-si, Suwon, Yangsan, Bupyeong-gu, Seoul
2024-05-08
Active, closed
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
NCT06372145Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
Sanofi
Phase 3
2,500
Goyang-si, Seoul
2024-04-16
Active, closed
Sanofi
Phase 3
943
Goyang-si, Seongnam-si, Seoul
2023-12-27
Active, closed
Sanofi
Phase 3
1,655
Goyang-si, Seongnam-si, Seoul
2023-12-13
Recruiting
Sanofi
Phase 3
180
Yangsan, Seoul
2023-10-10
Active, closed
Sanofi
Phase 2
999
Ansan-si, Bucheon-si, Yangsan, Incheon, Seoul
2023-04-03
Active, closed
Sanofi
Phase 2/3
1,856
Daegu, Gwangju, Ansan-si, Seongnam-si, Suwon, Yangsan, Bupyeong-Gu, Seoul
2022-08-22
Active, closed
Sanofi
Phase 4
1,339
Busan, Wŏnju, Daegu, Bupyeong-Gu, Seoul
2021-12-16
Recruiting
Sanofi
Phase 1/2
258
Seoul
2021-01-25
Active, closed
Sanofi
Phase 3
337
Gangnam-gu, Seoul
2020-06-16
Active, closed
Sanofi
Observational
1,860
Ansan-si, Suwon, Incheon, Seoul
2019-08-15
Rows per page Showing 1–30 of 30
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-south-korea/city/seoul

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,365 studies in total at the last sync on 11 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 30 of those studies with a site in Seoul that also match the filters currently applied.

How many clinical trials are recruiting in Seoul?

10 of the 30 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:17 UTC sync. A further 1 have not yet opened recruitment, 16 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Seoul), 30 studies
PhaseStudiesRecruitingShare
Phase 319663.3%
Observational3110%
Phase 23010%
Phase 4216.7%
Phase 1113.3%
Phase 1/2113.3%
Phase 2/3103.3%

Most active sponsors

Lead sponsors with the most studies (Seoul)
Lead sponsorStudiesRecruiting
Sanofi3010
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.